RayBiotech Life, Inc.
Records under this name other than the patents RayBiotech Life, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 2 of 2 · Back to RayBiotech Life, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,255,855 | COVID-19 spike-ACE2 binding assay for drug and antibody screening Lapsed on the fee record Ended Feb 22, 2026 · USPTO record | Lapsed on the fee record | Ended Feb 22, 2026 | USPTO record |
| US 11,249,083 | Covid-19 spike-ACE2 binding assay for drug and antibody screening Lapsed on the fee record Ended Feb 15, 2026 · USPTO record | Lapsed on the fee record | Ended Feb 15, 2026 | USPTO record |